Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2009 11:01

RNS Number : 2364W
Skyepharma PLC
24 July 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SKYEPHARMA PLC

GB00B3BFNB64

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 N/A

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

N/A 

An event changing the breakdown of voting rights

N/A 

Other (please specify):

N/A 

3. Full name of person(s) subject to the notification obligation:

 UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3.):

 UBS AG LONDON BRANCH

5. Date of the transaction and date on which the threshold is crossed or reached:

 22 JULY 2009

6. Date on which issuer notified:

 24 JULY 2009

7. Threshold(s) that is/are crossed or reached:

 6.07%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

 1,147,010

 1,147,010

 1,452,702

 1,452,702

 -

 6.07%

 -

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,452,702

 6.07%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 ESTEBAN FRANK/ALEXA KOENIG

15. Contact telephone number:

 +41 44 239 5476

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKZLBLKDBZBBD
Date   Source Headline
28th Sep 20114:10 pmRNSSkyePharma: NDA submission in US for Lodotra in RA
12th Sep 201112:00 pmRNSHolding(s) in Company
9th Sep 20112:15 pmRNSHolding(s) in Company
7th Sep 20115:15 pmRNSDirector/PDMR Shareholding
7th Sep 20117:00 amRNSHead of Sales and Business Development Appointed
2nd Sep 20111:10 pmRNSUpdate on Diabetes Product Candidate
18th Aug 20117:00 amRNSHalf Yearly Report
17th Aug 20117:00 amRNSRe Agreement
8th Aug 20114:37 pmRNSDirector/PDMR Shareholding
8th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 201111:18 amRNSHolding(s) in Company
3rd Aug 20117:00 amRNSNotice of Results
1st Aug 20117:00 amRNSAmendment to CRC Finance Facility
1st Aug 20117:00 amRNSRe Alliance with the Aenova Group
28th Jul 20117:00 amRNSRe Agreement
12th Jul 20114:41 pmRNSSecond Price Monitoring Extn
12th Jul 20114:35 pmRNSPrice Monitoring Extension
8th Jul 20114:35 pmRNSPrice Monitoring Extension
7th Jul 20112:52 pmRNSDirector/PDMR Shareholding
24th Jun 20114:35 pmRNSPrice Monitoring Extension
23rd Jun 20114:35 pmRNSPrice Monitoring Extension
21st Jun 20114:40 pmRNSSecond Price Monitoring Extn
21st Jun 20114:35 pmRNSPrice Monitoring Extension
6th Jun 20115:06 pmRNSDirector/PDMR Shareholding
1st Jun 20114:40 pmRNSSecond Price Monitoring Extn
1st Jun 20114:35 pmRNSPrice Monitoring Extension
24th May 20114:40 pmRNSSecond Price Monitoring Extn
24th May 20114:35 pmRNSPrice Monitoring Extension
23rd May 20114:40 pmRNSSecond Price Monitoring Extn
23rd May 20114:36 pmRNSPrice Monitoring Extension
20th May 201111:20 amRNSDirector/PDMR Shareholding
19th May 20114:35 pmRNSPrice Monitoring Extension
13th May 20114:40 pmRNSSecond Price Monitoring Extn
13th May 20114:35 pmRNSPrice Monitoring Extension
12th May 201112:28 pmRNSAGM Results
12th May 20117:00 amRNSInterim Management Statement
10th May 20114:41 pmRNSSecond Price Monitoring Extn
10th May 20114:35 pmRNSPrice Monitoring Extension
6th May 20114:40 pmRNSSecond Price Monitoring Extn
6th May 20114:35 pmRNSPrice Monitoring Extension
5th May 20114:40 pmRNSSecond Price Monitoring Extn
5th May 20114:35 pmRNSPrice Monitoring Extension
4th May 20114:35 pmRNSPrice Monitoring Extension
3rd May 20114:35 pmRNSPrice Monitoring Extension
27th Apr 20114:40 pmRNSSecond Price Monitoring Extn
27th Apr 20114:35 pmRNSPrice Monitoring Extension
26th Apr 20114:35 pmRNSPrice Monitoring Extension
26th Apr 20113:47 pmRNSAnnual Information Update
11th Apr 20115:10 pmRNSDirector/PDMR Shareholding
7th Apr 20113:26 pmRNSAnnual Report and Accounts 2010

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.